Juan Gómez

发表

Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients

E. Coto, G. M. Albaiceta, E. Cuesta-Llavona, 2022, Human Immunology.

FURIN gene variants (rs6224/rs4702) as potential markers of death and cardiovascular traits in severe COVID‐19

V. Álvarez, E. Coto, G. M. Albaiceta, 2022, Journal of medical virology.

Association between the interferon-induced transmembrane protein 3 gene (IFITM3) rs34481144 / rs12252 haplotypes and COVID-19

E. Coto, E. Cuesta-Llavona, Daniel Vázquez-Coto, 2021, Current Research in Virological Science.

Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome

V. Álvarez, E. Coto, C. López-Larrea, 2020, Gene.

Left ventricular non-compaction associated with a MYH7 splicing variant (c.818+1G>A)

E. Coto, C. Corros, J. Reguero, 2022, Journal of Clinical Images and Medical Case Reports.

IGHG3 hinge length variation was associated with the risk of critical disease and death in a Spanish COVID-19 cohort

V. Álvarez, E. Coto, H. Gil-Peña, 2022, Genes & Immunity.

Common mitochondrial haplogroups as modifiers of the onset-age for critical COVID-19

E. Coto, E. Cuesta-Llavona, Daniel Vázquez-Coto, 2022, Mitochondrion.

Age-dependent effect of the IFIH1/MDA5 gene variants on the risk of critical COVID-19

V. Álvarez, E. Coto, E. Cuesta-Llavona, 2022, Immunogenetics.

Mitochondrial DNA Poly-C length heteroplasmy as a marker for risk of critical COVID-19

E. Coto, Daniel Vázquez-Coto, L. Amado-Rodríguez, 2023 .

Capillary electrophoresis of PCR fragments with 5´-labelled primers for testing the SARS-Cov-2

V. Álvarez, E. Coto, E. Cuesta-Llavona, 2020, Journal of Virological Methods.